Study of the adjuvant properties of beta-glucans from <i>Saccharomyces Cerevisiae</i> yeast-Reference-Cited by-同舟云学术

Study of the adjuvant properties of beta-glucans from <i>Saccharomyces Cerevisiae</i> yeast

Published:2024-07-28 Issue:3 Volume:14 Page:569-574
ISSN:2313-7398
Container-title:Russian Journal of Infection and Immunity
language:
Short-container-title:Russian Journal of Infection and Immunity

Author:

Volosnikova Ekaterina A.,Shcherbakov D. N.,Volkova N. V.,Esina T. I.,Zaikovskaya A. V.,Shimina G. G.,Danilenko E. D.

Abstract

To increase the effectiveness and immunogenicity of modern vaccines, especially subunit ones, it is required to use adjuvants. Polysaccharides, due to their safety and biocompatibility, are desirable candidates for the creation of vaccine adjuvants. The aim of our study was to develop a method for obtaining beta-Glucans from the yeast Saccharomyces cerevisiae cell wall, and evaluate their adjuvant properties. The high purity and non-toxicity of the resulting preparation was achieved by using enzyme complexes of cellulase and protease in combination with ultrasound (22 kHz) at the purification stage. The developed scheme allows for the yield of beta-Glucans up to 2 g from 100 g of the biomass of wet cells. The adjuvant properties of beta-Glucans were studied in 50 male BALB/c mice, weighing 16–18 g. Immunization was performed twice, with a 14-day interval, intramuscularly, 200 μl per animal. The recombinant receptor-binding domain (RBD) of the surface S protein of the SARS-CoV-2 virus (Wuhan-Hu-1 and B.1.617.2 (Delta)) was used as an antigen, at a dose of 50 μg per animal. A positive control group was administered with the antigen combined with aluminum hydroxide. As a negative control, mice injected with the saline solution were used. The titers of specific antibodies in the blood sera were determined by ELISA assays. RBD (Wuhan-Hu-1 and Delta), and S protein (Wuhan-Hu-1, Delta and Omicron) were used as antigens. The titers of virus-neutralizing antibodies were measured in neutralization tests using SARS-CoV-2 virus strains Wuhan-Hu-1, Delta (B.1.617.2) and Omicron (B.1.1.529). The results of the study have shown that beta-Glucans have the ability to enhance the production of specific and virus-neutralizing antibodies in mice immunized with RBD. The titers of specific and virus neutralizing antibodies are comparable to their levels in the group immunized with RBD and Al(OH)₃. It has been found in the experiments in white outbred ICR mice that the preparation belongs to practically non-toxic substances. Therefore, it can be concluded that the use of beta-Glucans could become a preferable alternative to the conventional adjuvants based on aluminum salts, being biocompatible, biodegradable and non-toxic substances of low labor-intensive production.

Publisher

SPb RAACI

Reference8 articles.

1. Дьякон А.В., Хрыкина И.С., Хегай А.А., Дьяченко И.А., Мурашев А.Н., Ивашев М.Н. Метод забора крови у животных // Международный журнал прикладных и фундаментальных исследований. 2013. Т. 11, № 2. С. 84–85. [Dyakon A.V., Hrykina I.S., Hegai A.A., Dyachenko A., Murashev A.N., Ivashev M.N. Method for blood sampling in animals. Mezhdunarodnyy zhurnal prikladnykh i fundamentalnykh issledovaniy = International Journal of Applied and Fundamental Research, 2013, vol. 11, no. 2, pp. 84–85. (In Russ.)]

2. Измеров Н.Ф., Саноцкий И.В., Сидоров К.К. Параметры токсикометрии промышленных ядов при однократном воздействии (Справочник). М.: Медицина, 1977. 240 c. [Izmerov N.F., Sanotsky I.V., Sidorov K.K. Parameters of Toxicometry of Industrial Poisons with a Single Exposure (Reference Book). Moscow: Meditsina, 1977. 240 p. (In Russ.)]

3. Курашова С.С., Дзагурова Т.К. Ишмухаметов А.А., Егорова М.С., Баловнева М.В., Соцкова С.Е., Ткаченко Е.А. Адъюванты на основе углеводов для производства вакцин // БИОпрепараты. Профилактика, диагностика, лечение, 2018. Т. 18, № 2. С. 81–91. [Kurashova S.S., Dzagurova Т.К., Ishmukhametov А.А., Egorova М.S., Balovneva М.V., Sotskova S.E., Tkachenko Е.А. Carbohydrate-Based Adjuvants for Vaccine Production. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIOpreparations. Prevention, Diagnosis, Treatment, 2018, vol. 18, no. 2, pp. 81–91. (In Russ.)]

4. Методические указания по оценке токсичности и опасности дезинфицирующих средств МУ 1.2.110⁵02, утвержденные Главным государственным санитарным врачом РФ 10.02.2002. М., 2002. [Evaluation of the toxicity and hazards of disinfectants: guidelines 1.2.110⁵-02: approved by the Chief State Sanitary Doctor of the Russian Federation on 10.02.2002]. Moscow, 2002. URL: https://docs.cntd.ru/document/1200030376/titles

5. Прозоровский В.Б., Прозоровская М.Н., Демченко В.М. Экспресс-метод определения средней эффективной дозы и ее ошибки // Фармакология и токсикология, 1978. Т. 41, № 4. С. 497–502. [Prozorovsky V.B., Prozorovskaya M.P., Demchenko V.M. A rapid method for the determination of the median effective dose and its errors. Farmakologiya i toksikologiya = Pharmacology and Toxicology, 1978, vol. 41, no. 4, pp. 497–502. (In Russ.)]